AIM ImmunoTech Inc. (AIM) stock
AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.15+0.00 (+0.13%)
Close on Nov 12, 2026Market cap $4.52MP/E –Yield –
AIM ImmunoTech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
AIM ImmunoTech's enterprise value was -$2.04M on Nov 11, 2026, against $3.67M a year earlier. Over the last 5 years it ranged from -$21.84M to $12.17M, with a median of $1.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.04M | -178.8% |
| 2025 | Dec 31, 2025 | $2.59M | -63.7% |
| 2024 | Dec 31, 2024 | $7.13M | – |
| 2023 | Dec 29, 2023 | -$986.40K | – |
| 2022 | Dec 30, 2022 | -$21.84M | – |
| 2021 | Dec 31, 2021 | -$9.68M | -147.4% |
| 2020 | Dec 31, 2020 | $20.44M | – |
| 2019 | Dec 31, 2019 | -$2.07M | -128.9% |
| 2018 | Dec 31, 2018 | $7.18M | -39.3% |
| 2017 | Dec 29, 2017 | $11.84M | -2.5% |
| 2016 | Dec 30, 2016 | $12.14M | -34.9% |
| 2015 | Dec 31, 2015 | $18.65M | -60.5% |
| 2014 | Dec 31, 2014 | $47.17M | +8.1% |
| 2013 | Dec 31, 2013 | $43.64M | +29.4% |
| 2012 | Dec 31, 2012 | $33.72M | +46.1% |
| 2011 | Dec 30, 2011 | $23.09M | – |
See a number that looks wrong?